시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 환자 피부 소독용 글루콘산클로르헥시딘 제품 시장, 분석 및 예측(2019-2030년)
Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Report, History and Forecast 2019-2030
상품코드 : 1594236
리서치사 : QYResearch
발행일 : 2024년 11월
페이지 정보 : 영문
 라이선스 & 가격 (부가세 별도)
US $ 3,350 ￦ 4,847,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,025 ￦ 7,270,000
PDF (Multi User License) help
PDF 보고서를 동일 사업장에서 10명까지 이용할 수 있는 라이선스입니다. PDF 내용의 텍스트 등을 Copy & Paste 할 수 있습니다. 인쇄 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,700 ￦ 9,694,000
PDF (Enterprise User License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계 환자 피부 소독용 글루콘산클로르헥시딘 제품 시장 규모는 2023년 6억 8,844만 달러로 평가되었고, 2030년까지 7억 8,046만 달러에 달할 것으로 예상되며, 2024-2030년의 예측 기간 동안 연평균 3.64% 성장할 것으로 예상됩니다.

북미 시장 규모는 2023년 2억 1,701만 달러로 평가되었고, 2030년까지 2억 7,006만 달러에 달할 것으로 예상되며, 예측 기간 동안 연평균 3.21%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

아시아태평양 시장 규모는 2023년 1억 3,556만 달러로 평가되었고, 2030년까지 1억 8,410만 달러에 달할 것으로 예상되며, 예측 기간 동안 4.39%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

유럽 시장 규모는 2023년 2억 2,500만 달러로 평가되었고, 2030년까지 2억 6,066만 달러에 달할 것으로 예상되며, 예측 기간 동안 연평균 3.73%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

이 보고서는 세계의 환자 피부 소독용 글루콘산클로르헥시딘 제품 시장을 조사 분석했으며, 각 지역별 시장 규모와 예측, 경쟁 구도, 기업 프로파일, 기술 동향, 신제품 개발 등의 정보를 전해드립니다.

목차

제1장 환자 피부 소독용 글루콘산클로르헥시딘 제품 시장 개요

제2장 환자 피부 소독용 글루콘산클로르헥시딘 제품 각사 시장 경쟁

제3장 환자 피부 소독용 글루콘산클로르헥시딘 제품 현황과 전망 : 지역별

제4장의 환자 피부 소독용 글루콘산클로르헥시딘 제품 : 용도별

제5장 북미의 환자 피부 소독용 글루콘산클로르헥시딘 제품 : 국가별

제6장 유럽의 환자 피부 소독용 글루콘산클로르헥시딘 제품 : 국가별

제7장 아시아태평양의 환자 피부 소독용 글루콘산클로르헥시딘 제품 : 지역별

제8장 라틴아메리카의 환자 피부 소독용 글루콘산클로르헥시딘 제품 : 국가별

제9장 중동 및 아프리카의 환자 피부 소독용 글루콘산클로르헥시딘 제품 : 국가별

제10장 기업 개요

제11장 업스트림(Upstream), 기회, 과제, 리스크, 영향요인 분석

제12장 마케팅 전략 분석, 판매업체

제13장 조사 결과와 결론

제14장 부록

LSH
영문 목차

영문목차

The global market for Chlorhexidine Gluconate Product for Patient Skin Antisepsis was valued at $ 608.44 million in 2023 and will reach $ 780.46 million by 2030, at a CAGR of 3.64% during the forecast period of 2024 through 2030.

North American market for Chlorhexidine Gluconate Product for Patient Skin Antisepsis was valued at $ 217.01 million in 2023 and will reach $ 270.06 million by 2030, at a CAGR of 3.21% during the forecast period of 2024 through 2030.

Asia-Pacific market for Chlorhexidine Gluconate Product for Patient Skin Antisepsis was valued at $ 135.56 million in 2023 and will reach $ 184.10 million by 2030, at a CAGR of 4.39% during the forecast period of 2024 through 2030.

Europe market for Chlorhexidine Gluconate Product for Patient Skin Antisepsis was valued at $ 202.50 million in 2023 and will reach $ 260.66 million by 2030, at a CAGR of 3.73% during the forecast period of 2024 through 2030.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chlorhexidine Gluconate Product for Patient Skin Antisepsis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Chlorhexidine Gluconate Product for Patient Skin Antisepsis.

The Chlorhexidine Gluconate Product for Patient Skin Antisepsis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chlorhexidine Gluconate Product for Patient Skin Antisepsis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chlorhexidine Gluconate Product for Patient Skin Antisepsis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Chlorhexidine Gluconate Product for Patient Skin Antisepsis segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2019-2023, 2024-2030), considering 2023 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

Segment by Type

Segment by Application

By Region

Chapter Outline

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Two: Detailed analysis of Chlorhexidine Gluconate Product for Patient Skin Antisepsis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of Chlorhexidine Gluconate Product for Patient Skin Antisepsis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Analysis of sales channel, distributors and customers.

Chapter Thirteen: Research Findings and Conclusion.

Table of Contents

1 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Overview

2 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Competition by Company

3 Chlorhexidine Gluconate Product for Patient Skin Antisepsis Status and Outlook by Region

4 Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Application

5 North America Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Country

6 Europe Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Country

7 Asia-Pacific Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Region

8 Latin America Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Country

9 Middle East and Africa Chlorhexidine Gluconate Product for Patient Skin Antisepsis by Country

10 Company Profiles

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

12 Marketing Strategy Analysis, Distributors

13 Research Findings and Conclusion

14 Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기